|
h-R3 MaB and radiotherapy in pediatric patients with intrinsic diffuse astrocytomas of brain stem, phase II. |
2010-12-28 |
CIM |
|
NAcGM3/VSSP/Montanide ISA 51 formulation in HIV, phase II. |
2010-12-29 |
CIM |
|
hR3 MAb in combination with chemo-embolization in hepatocellular carcinoma. |
2010-12-29 |
CIM |
|
hR3 monoclonal antibody combined with chemoembolization in mestatatic liver treatment. |
2010-12-29 |
CIM |
|
Early use of surfacen in the respiratory distress syndrome of the newborn. Phase IV |
2011-04-18 |
CENSA |
|
TS-FARMEV Study |
2011-05-16 |
CIGB |
|
HeberproGen Study |
2011-05-20 |
CIGB |
|
MAGINC Study |
2011-07-12 |
CIGB |
|
Effectiveness and safety of ior®EPOCIM in Chronic Kidney Disease patients in pre-dialysis. |
2011-11-11 |
CIMAB |
|
Therapeutic clinical evaluation of the Plectranthus amboinicus Lour Spreng (Oregano French) tablets in patient with common cold |
2011-11-22 |
CIDEM |
|
Nimotuzumab in tumors of head and neck .Phase IV |
2013-02-01 |
CIMAB |
|
Pharmacokinetics of the Intralesional administration of rhEGF (doses: 75 µg and 225 µg) in advance Diabetic Foot Ulcers |
2013-02-08 |
CIGB |
|
Pneumococcal conjugate vaccination among Warao children |
2013-06-14 |
SAIB |
|
Biomodulin T-IM-oncological adults post chemotherapy-prevention COVID-19. Exploratory study |
21/12/2020 |
BIOCEN |
|
Totally Laparoscopic Hysterectomy with Single-Port Access. Validation of a new technique in Cuba. |
22/04/2014 |
CNCMA |
|
Evaluation of the synergistic effect of sequential administration of two immunostimulant products: Immuno-1 and Immuno-2 for the stimulation of the immune response in older adults. Exploratory study |
22/05/2020 |
FINLAY |
|
VA-MENGOC-BC to stimulate the innate response against SARS-CoV-2 |
22/05/2020 |
FINLAY |
|
VIDA study |
22/06/2020 |
CIGB |
|
Interferon Combination in basal cell carcinoma (InCarbacel-IV study) |
22/08/2013 |
CIGB |
|
Phase II / III. Nimotuzumab in patients with triple-negative breast cancer. |
23/05/2014 |
CIM |
